Physician profile
Robert T Coles
NPI 1407876691
$231.92
in general payments reported to CMS, 2019-2025
6 companies · $40.10 in 2025
The $40.10 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.54 · 2023: $73.59 · 2024: $103 · 2025: $40.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $57.47 | 2023-2024 | Bexsero, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $56.03 | 2024-2025 | Gardasil 9, Gardasil, M-M-R II |
| Cranial Technologies, INC | $42.93 | 2022-2023 | Doc Band |
| Sanofi Pasteur INC. | $38.41 | 2023-2025 | |
| Biomarin Pharmaceutical INC. | $23.79 | 2024 | Voxzogo 1.2mg |
| Phadia US INC. | $13.29 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Coles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.